Hotta M, Kuriyama H, Arai K, Takano K, Shibasaki T.

Fibroblast growth factor inhibits locomotor activity as well as feeding behavior of rats. EUR J PHARMACOL 2001;416(1-2):101-106

Jahn H, Montkowski A, Knaudt K, Strohle A. et al.

a-helical-corticotropin-releasing hormone reverses anxiogenic effects of C-type natriuretic peptide in rats.

BRAIN RES 2001;893(1-2):21-28

Jerabek I, Boulenger JP, Bradwejn J, Lavallee YJ, Jolicoeur FB.

CCK4-induced panic in healthy subjects I: psychological and cardial effects. EUR NEUROPSYCHOPHARMACOL 1999;9(1-2):149-155

Johnston ANB, Clements MP, Rose SPR.

Role of brain-derived neurotrophic factor and presynaptic proteins in passive avoidance learning in day-old domestic chicks.

NEUROSCIENCE 1999;88(4):1033-1042

Kanatani A, Ishihara A, Asahi S, Tanaka T, Ozaki S, Ihara M.

Potent neuropeptide YY1 receptor antagonist, 1229U91: blockade of neuropiptide Y induced and physiological food intake.

ENDOCRINOLOGY 1996; 137 (8) : 3177-3182.

Kane JK, Parker SL, Li MD.

Hypothalamic orexin-A binding sites are downregulated by chronic nicotine treatment in the rat. NEUROSCI LETT 2001;298(1):1-4

Katovich MJ, Aerni JD, Cespedes AT, Rowland NE.

Perinatal dietary NaCl level: effect on angiotensin induced thermal and dipsogenic responses in adult rats.

PHYSIOL BEHAV 2001;72(4):621-627

Kenny PJ, File SE, Rattray M.

Acute nicotine decreases, and chronic nicotine increases the expression of brain-derived neurotrophic factor mRNA in rat hippocampus.

MOL BRAIN RES 2000;85(1-2):234-238

Kerekes N, Landry M, Rydhrinder M, Hokfelt T.

The effect of NGF, BDNF and BFGF on expression of galanin in cultured rat dorsal root ganglia. BRAIN RES 1997;754(1-2):131-141

Kline AE, Montanez S, Bradley HA, Millar CJ, Hernandez TD.

Distinctive amygdala kindled seizures differentially affect neurobehavioral recovery and lesion-induced basic fibroblast growth factor (BFGF) expression. BRAIN RES 2000;880(1-2):38-50

Kofler N, Kirchmair E, Schwarzer C, Sperk G.

Altered expression of NPY-Y-1 receptors in kainic acid induced epilepsy in rats. NEUROSCI LRTT 1997;230(2):129-132

Kramar et al. Armstrong DL, Ikeda S, Wayner M, Harding J, Wright JW.

The effects of angiotensin IV analogs on long-term potentiation within the CA1 region of the hippocampus in vitro.

BRAIN RES 2001;897(1-2):114-121

Krzan M, Wu VW, Schwartz JP.

Serotonin regulation of nerve growth factor synthesis in neonatal and adult astrocytes: Comparison to the β-adrenergic agonist isoproterenol.

J NEUROSCI RES 2001;64(3):261-267

Kulkosky P.

Neuropeptidergic control of ethanol intake.

J TOXICOL TOXIN REVIEWS 1996;15(4):341-351

Lee J, Chai SY, Mendelsohn FAO, Morris MJ, Allen AM.

Potentiation of cholinergic transmission in the rat hippocampus by angiotensin IV and LVV-hemorphin-7. NEUROPHARMACOLOGY 2001;40(4):618-623

Lindholm S, Ploj K, Franck J, Nylander I.

Repeated ethanol administration induces short- and longterm changes in enkephalin and dynorphin tissue concentrations in rat brain.

ALCOHOL 2000;22(3):165-171

Lopes P, Couture R.

Localization of bradykinin like immunoreactivity in the rat spinal cord: effects of capsaicin, melittin, dorsal rhizotomy and peripheral axotomy.

NEUROSCIENCE 1997;78(2):481-497

Lu L, Huang MS, Ma L, Li J.

Different role of cholecystokinin (CCK)-A and CCK-B receptors in relapse to morphine dependence in rats.

BEHAV BRAIN RES 2001;120(1):105-110

Lu L, Liu DH, Ceng XB, Ma L.

Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence.

EUR J NEUROSCI 2000;12(12):4398-4404

Lurton D, Cavalheiro EA

Neuropeptide-Y immunoreactivity in the pilocarpine model of temporal lobe epilepsy. EXPER BRAIN RES 1997;116(1):186-190

Lynch SA, Elton CW, Carver FM, Pennington SN.

Alcohol-induced modulation of the insulin-like growth factor system in early chick embryo cranial tissue.

ALCOHOL CLIN EXP RES 2001;25(5):755-763

Madeira MD, Andrade JP, Lieberman AR, Sousa N. et al.

Chronic alcohol consumption and withdrawal do not induce cell death in the suprachiasmatic nucleus, but lead to irreversible depression of peptide immuno-reactivity and mRNA levels.

J NEUROSCI 1997;17(4):1302-1319

Malcangio M, Bowery N.

Calcitonin gene related peptide content, basal outflow and electrically evoked release from monoarthritic rat spinal cord in vitro.

PAIN 1996;66(2-3):351-358

Marks JL, Waite K.

Some acute effects of intracerebroventricular neuropeptide Y on insulin secretion and glucose metabolism in the rat.

J NEUROENDOCRINOL 1996; 8 (7) : 507-513.

Mathis JP, Rossi GC, Pellegrino MJ, Jimenez C. et al.

Carboxyl terminal peptides derived from prepro-orphanin FQ/nociceptin (PpOFQ/N) are produced in the hypothalamus and possess analgesic bioactivities.

BRAIN RES 2001;895(1-2):89-94

Miller K, Lupica Cr.

Neuropeptide FF inhibition of morphine effects in the rat hippocampus BRAIN RES 1997;750(1-2):81-86

Munglani R, Harrison S, Smith G, Bountra C, Birch P, Elliot P, Hunt S.

Neuropeptide changes persist in spinal cord despite resolving hyperalgesia in a rat model of mononeuropathy.

BRAIN RES 1996;743(1-2):102-108

Myers RD,Lankford MF, Roscoe AK.

Neuropeptide Y perfused in the preoptic area of rats shifts extracellular efflux of dopamine, norepinephrine, and serotonin during hypothermia and feeding.

Neurochemical-Research. 1996; 21 (6) : 637-648.

Narita M, Dun S, Dun N, Tseng L.

Hyperalgesia induced by pituitary adenylate cyclase activating polypeptide in the mouse spinal cord. EUROP J PHARMACOL 1996;311(2-3):121-126

Nelson CJ, Lysle DT.

Involvement of substance P and central opioid receptors in morphine modu-lation of the CHS response.

J NEUROIMMUNOL 2001;115(1-2):101-110

Neumann S, Doubell T, Leslie T, Woolf C.

Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons.

NATURE 1996;384(6607):360-364

Okusky JR, Ye P, Dercole AJ.

Insulin-like growth factor-I promotes neurogenesis and synaptogenesis in the hippocampal dentate gyrus during postnatal development.

J NEUROSCI 2000;20(22):8435-8442

Oldfield BJ, Davern PJ, Giles ME, Allen AM. et al.

Efferent neural projections of angiotensin receptor (AT(1)) expressing neurones in the hypothalamic paraventricular nucleus of the rat.

J NEUROENDOCRINOL 2001;13(2):139-146

Palkovits M, Baffi JS, Berzsenyi P, Horvath EJ.

Anxiolytic homophthalazines increase Fos-like immunoreactivity in brain areas. EUROP J PHARMACOL 1997;331(1):53-63

Penkowa M, Molinero A, Carrasco J, Hidalgo J.

Interleukin-6 deficiency reduces the brain inflammatory response and increases oxidative stress and neurodegeneration after kainic acid-induced seizures.

NEUROSCIENCE 2001;102(4):805-818

Piwko C, Thoss V, Samanin R, Hoyer D, Vezzani A.

Status of somatostatin receptor messenger rnas and binding sites in rat brain during kindling epileptogenesis.

NEUROSCIENCE 1996;75(3):857-868

Przewlocka B, Lason W, Przewlocki R.

Repeated ethanol administration decreases prodynorphin biosynthesis in the rat hippocampus. NEUROSCI LETT 1992;134(2):195-208

Rady JJ, Campbell WB, Fujimoto JM.

Antianalgesic action of nociceptin originating in the brain is mediated by spinal prostaglandin E-2 in mice.

J PHARMACOL EXP THER 2001;296(1):7-14

Rossi GC, Leventhal L, Bolan E, Pasternak GW.

Pharmacological characterization of orphanin FQ/nociceptin and its fragments. J PHARMACOL EXP THER 1997;282(2):858-865

Rothman RB.

A review of the role of anti-opioid peptides in morphine tolerance and dependence. SYNAPSE 1992;12(2):129-138

Roudenok V.

Changes in the expression of neuropeptide Y during maturation of human sympathetic ganglionic neurons: correlation with tyrosine hydroxylase immuno-reactivity.

ANN ANATOMY 2000;182(6):515-519

Rovere C, Viale A, Nahon JL, Kitabgi P.

Impaired processing of brain proneurotensin and promelanin concentrating hormone in obese fat/fat mice.

ENDOCRINOLOGY 1996; 137 (7) : 2954-2958.

Sandin J, Ogren SO, Terenius L.

Endomorphin-2 but not Leu-enkephalin modulates spatial learning when injected in CA3 region of the rat hippocampus.

NEUROREPORT 2000;11(17):3659-3662

Santarelli L, Gobbi G, Debs PC, Sibille EL. et al.

Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function.

PROC NAT ACAD SCI USA 2001;98(4):1912-1917

Schwartz MW, Seeley RJ, Campfield LA, Burn P, Baskin DG.

Identification of targets of leptin action in rat hypothalamus J CLIN INVEST 1996; 98 (5) : 1101-1106.

Schwarzer C, Marksteiner J, Kroesen S, Kohl C, Sperk G, Winkler H.

Secretoneurin: a marker in rat hippocampal pathways. J COMPAR NEUROLOGY 1997;377(1):29-40

Schwarzer C, Sperk G, Samanin R, Rizzi M, Gariboldi M, Vezzani A.

Neuropeptides immunoreactivity and their mRNA expression in kindling: functional implications for limbic epileptogenesis.

BRAIN RES REVIEWS 1996;22(1):27-50

Не нашли, что искали? Воспользуйтесь поиском по сайту: